Stephan Dietrich A 4
4 · NeuBase Therapeutics, Inc. · Filed Sep 30, 2022
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Stock
2022-09-28$0.00/sh+750,000$825→ 816,775 total - Exercise/Conversion
Stock option (right to buy)
2022-09-28$0.00/sh−750,000$825→ 2,519,680 totalExercise: $0.00From: 2019-07-12Exp: 2023-12-31→ Common Stock (750,000 underlying)
Holdings
- 1,273,819(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by the reporting person as a tenant by the entirety with his spouse.
- [F2]These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.